Gland Pharma and Neuland Labs enter into strategic partnership

Metro India News | Hyderabad 

Gland Pharma Limited ("Gland Pharma") and Neuland Laboratories Limited ("Neuland") announced on Wednesday a long-term strategic CDMO partnership. Under the partnership Gland will establish a sterile manufacturing suite for Active Pharmaceutical Ingredients (APIs). The collaboration combines Neuland's Complex API development and manufacturing capabilities with Gland Pharma's global sterile manufacturing expertise and strong regulatory compliance track record.

Under the collaboration, Gland Pharma will expand its existing sterile manufacturing infrastructure through an additional dedicated suite at its JNPC facility at Visakhapatnam to support Neuland for its growing demand of sterile APIs. The partnership is expected to enhance supply resilience globally by combining Neuland's development and regulatory expertise with Gland Pharma's manufacturing capabilities.

Srinivas Sadu, Executive Chairman, Gland Pharma Limited mentioned that by leveraging the complementary strengths of both organizations, a robust and scalable CDMO solution is expected to be provided. Saharsh Davuluri, CEO & MD, Neuland Laboratories Limited, said that through this partnership with Gland Pharma, Neuland's expertise in complex APIs is being combined with Gland's proven sterile manufacturing capabilities to create a differentiated platform for global customers.